Bruno Fattizzo

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 184 publications

Anemia and Patient-Reported Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Observational Study.

Anemia and Patient-Reported Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Observational Study.

Journal: EJHaem
Published: July 13, 2026

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment.

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment.

Journal: Expert review of hematology
Published: July 08, 2026

Refractory autoimmune hemolytic anemia with poor erythropoietic compensation in combined immunodeficiency: A case series.

Refractory autoimmune hemolytic anemia with poor erythropoietic compensation in combined immunodeficiency: A case series.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: May 23, 2026

Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments.

Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments.

Journal: European journal of haematology
Published: May 04, 2026

Decoding the Ektacytometric Landscape of Hereditary Spherocytosis: Insights from 204 Cases.

Decoding the Ektacytometric Landscape of Hereditary Spherocytosis: Insights from 204 Cases.

Journal: Diagnostics (Basel, Switzerland)
Published: April 30, 2026

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Journal: Blood
Published: April 01, 2026

Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety.

Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety.

Journal: HemaSphere
Published: March 02, 2026

Standardized diagnostic approach for cold agglutinin disease: results from a Delphi-Based Expert Consensus.

Standardized diagnostic approach for cold agglutinin disease: results from a Delphi-Based Expert Consensus.

Journal: Blood transfusion = Trasfusione del sangue
Published: February 16, 2026

Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.

Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.

Journal: Annals of hematology
Published: January 30, 2026

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Journal: American journal of hematology
Published: January 30, 2026

Navigating boundaries of autoimmunity in rare anemias: anti-erythropoietin antibody-mediated pure red cell aplasia in a patient with cold agglutinin disease.

Navigating boundaries of autoimmunity in rare anemias: anti-erythropoietin antibody-mediated pure red cell aplasia in a patient with cold agglutinin disease.

Journal: Blood transfusion = Trasfusione del sangue
Published: January 28, 2026

An Italian cartography of VEXAS-related thrombosis.

An Italian cartography of VEXAS-related thrombosis.

Journal: HemaSphere
Published: January 17, 2026
Showing 1-12 of 184

Last Updated: 09/26/2026